follow us:Google+ FacebookLinkedInTwitterRSS Feeds


Biopharmaceutical firm gets foreign investment


Back to Top Comments Email Print

Latest News


    An Indian company has invested in a Cranbury-based biopharmaceutical firm, the two companies announced Wednesday.

    Strides Arcolab, a global pharmaceutical company headquartered in Bangalore, India, has made a series of strategic investments in Oncobiologics Inc. which is developing a pipeline of biotherapeutics, the companies said in a news release.

    "The investments by Strides Arcolab represent important milestones for Oncobiologics,” Pankaj Mohan, Oncobiologics’ founder and CEO, said in the release. “Strides Arcolab is a long-term strategic partner that provides both financial strength and a proven track record of successful business ventures. We look forward to their support and guidance as we continue to execute Oncobiologics' business and technical plans."

    Terms of the investments were not disclosed.


    Three N.J. hospitals listed among area's best in U.S. News rankings

    Sandoz headquarters in Plainsboro sells for $64M

    Morgan Stanley hopes Newark program improves kids' wellness

    Share This Story On:
    Eric Strauss

    Eric Strauss

    Eric Strauss is the digital content editor for NJBIZ. He has been a reporter and editor for newspapers in New Jersey and Pennsylvania, as well as for a number of websites. You can contact him at or @acerimrat on Twitter.



    Be the first to comment.

    Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

    Post Comment
         View Comment Policy

    Advanced search
    Sponsored by
    Back to Top